Neuroscientist Greg Gerdeman, PhD, one of the rare professors to teach the endocannabinoid system in college, challenges health professionals and researchers to study cannabis science and therapeutics.
The 2016 meeting of the International Cannabinoid Research Society focused on the latest research in cannabinoid studies and the endocannabinoid system.
Clinical endocannabinoid deficiency and ways to target the endocannabinoid system for therapeutic benefit.
Long-term marijuana use is not associated with a raft of physical health problems, according to a new study, with one surprising exception: gum disease.
Greg Gerdeman, assistant professor of Biology at Eckerd College in St. Petersburg, Florida, recently spoke at the Annual Meeting of the Congress of Clinical Rheumatology on cannabinoid treatment for rheumatic diseases.
New scientific data shows that CBD interacts directly with the CB1 cannabinoid receptor in ways that are therapeutically relevant while modulating the psychoactive effects of THC. CBD lowers the ceiling on the ability of THC and endogenous cannabinoids to stimulate CB1. Cannabidiol is a profound mood-altering substance, even if it may not have a “high”.
Brain science, the neurobiology of stress, and moving away from the drug abuse paradigm.
Project CBD answers questions from our readers. This one is on vaporization and the boiling points of CBD & THC.
Kevin McKernan on sequencing the cannabis genome and its implications for the cannabis industry and “personalized medicine.”
New evidence marijuana users are much less likely to develop metabolic syndrome, a significant risk factor for obesity, diabetes, and heart disease.